Company / Gross Profit per Share
Idexx Laboratories Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$32.59
FY2025
5-year range
$22.11 / $32.59
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#9 of 94
Health Care
What the data says
Among 94 Health Care companies, Idexx Laboratories is in the top 10% for gross profit per share. Gross Profit per Share has increased for 9 consecutive years, from $9.61 in FY2016 to $32.59 in FY2025.
Based on SEC 10-K filings.
32.59 in FY2025 with a 5-year CAGR of +12.1%. Top quartile in the Health Care sector.
Improved from $26.42 to $32.59 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +11.2%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
+128.1% above sector average
Key checks
Key Insights
- Idexx Laboratories's gross profit per share has grown for 9 consecutive years.
- In FY2025, gross profit per share increased 13.8% year-over-year.
- Ranks #9 out of 94 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.59 | +13.8% |
| FY2024 | $28.65 | +8.4% |
| FY2023 | $26.42 | +11.5% |
| FY2022 | $23.70 | +7.2% |
| FY2021 | $22.11 | +20.3% |
| FY2020 | $18.38 | +15.9% |
| FY2019 | $15.86 | +11.3% |
| FY2018 | $14.25 | +21.6% |
| FY2017 | $11.72 | +21.9% |
| FY2016 | $9.61 | +16.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026